Medco, Sanofi Partner on PGx, Comparative Effectiveness | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Medco Health Solutions announced on Wednesday that it, its wholly owned subsidiary United BioSource, and Sanofi have entered into a global, multi-year agreement to improve patient care in real-world settings.

The partnership will leverage several capabilities, including personalized medicine and pharmacogenomics, health economics, and safety research, as well as clinical/adherence support.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.